<html>
<head>
<title>Federal Register, Volume 90 Issue 55 (Monday, March 24, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 55 (Monday, March 24, 2025)]
[Notices]
[Pages 13488-13489]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04914]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2025-0017]


Meeting of the Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment.

DATES: The meeting will be held on April 15, 2025, from 8 a.m. to 5:30 
p.m., EDT, April 16, 2025, from 8 a.m. to 5:30 p.m., EDT (times subject 
to change; see the ACIP website for updates: <a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>.
    Written comments must be received between March 31-April 11, 2025.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2025-
0017, by either of the methods listed below. CDC does not accept 
comments by email.
    <bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Follow the instructions for submitting comments.
    <bullet> Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, 
Atlanta, Georgia 30329-4027. Attn: Docket No. CDC-2025-0017.
    Instructions: All submissions received must include the Agency name 
and docket number. All relevant comments received will be posted 
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to .
    The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the ACIP website at <a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="mailto:ACIP@cdc.gov">ACIP@cdc.gov</a>.

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee on Immunization Practices (ACIP) is 
charged with advising the Director, Centers for Disease Control and 
Prevention (CDC), on the use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children program, along with schedules regarding dosing interval, 
dosage, and contraindications to administration of vaccines. Further, 
under applicable provisions of the Affordable Care Act and section 2713 
of the Public Health Service Act, immunization recommendations of ACIP 
that have been approved by the Director, CDC, and appear on CDC 
immunization schedules generally must be covered by applicable health 
plans.
    Matters to be Considered: The agenda will include discussions on 
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine, 
Human papillomavirus (HPV) vaccines, influenza vaccines, Lyme disease 
vaccine, meningococcal vaccines, mpox vaccines, pneumococcal vaccines, 
Respiratory Syncytial Virus (RSV) vaccines for adults, and RSV vaccines 
for maternal and pediatric populations. An update on the current 
measles outbreak will also be provided. Recommendation votes are 
scheduled for meningococcal vaccines, chikungunya vaccines, and RSV 
vaccines for adults. A Vaccines for Children (VFC) vote is scheduled 
for meningococcal vaccines. Agenda items are subject to change as 
priorities dictate. For more information on the meeting agenda, visit 
<a href="https://www.cdc.gov/acip/meetings/index.html">https://www.cdc.gov/acip/meetings/index.html</a>.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web. For more information on ACIP, please visit the ACIP website: 
<a href="https://www.cdc.gov/acip">https://www.cdc.gov/acip</a>.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near-duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: The docket will be opened to receive 
written comments March 31-April 11, 2025. Written comments must be 
received by April 11, 2025.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes, including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the

[[Page 13489]]

meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the April 15-16, 2025, ACIP meeting must 
submit a request at <a href="https://www.cdc.gov/acip/meetings/index.html">https://www.cdc.gov/acip/meetings/index.html</a> 
between March 31-April 11, 2025, and no later than 11:59 p.m., EDT, 
April 11, 2025 according to the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
random draw to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by April 14, 2025. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each 
speaker may speak only once per meeting.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2025-04914 Filed 3-21-25; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>